NFKB1 and neoplasm: Among the compounds characterized in COME, flavonoids have been largely studied for their anti-inflammatory and anti-tumor activity, and specific members of this family detected in the same extract, namely chrysin, quercetin-O-glucoside, and diosmetin, have been reported as NF-κB and AP-1 blockers [54,55,56,57,58].